Rubella and CRS case surveillance has been obligatory in Costa Rica since 1983 and is based on the clinical suspicion of any febrile eruptive disease case, which is then followed by a diagnostic ...

A diagnostic medical sonographer could be answering the question "Is it a boy or a girl?" as well as a host of other life-changing medical questions with the help of ultrasound technology.

The draw, held earlier this week, required candidates to have a minimum Comprehensive Ranking System (CRS) score of 727. This marks the third Express Entry draw of December. The first, on December 2, ...

Allergy and anatomic factors also play a role in chronic rhinosinusitis. The diagnosis of chronic rhinosinusitis requires both subjective symptoms as well as objective findings on physical ...

Additionally, data showed a median time to CR of 2.5 months (range, 1.2-5.4). Responses deepened from PRs to CRs in 7 patients, and of 9 who finished study treatment, 8 had sustained CRs at the time ...

11 with his cancer diagnosis, saying ... The cytoreductive surgery, or CRS, involves hyperthermic (heated) intraperitoneal chemotherapy, or HIPEC. "It attacks the cancer and has had a good ...

Most patients developed cytokine release syndrome (CRS); those with lower-grade CRS had better 1-year EFS outcomes than those with higher-grade CRS (P = .0191). Among the 172 patients with grade 1/2 ...

Haplo-HCT, increasingly used for treating haematologic malignancies, still carries significant risks, including life-threatening GvHD and cytokine release syndrome (CRS). While post-transplant ...

Non-relapse mortality (NRM) did not differ significantly. Severe cytokine release syndrome (CRS) occurred more than twice as often with cilta-cel, although the rate was low in both groups.

The researchers found that itacitinib resulted in low CRS grades; 22%, 78%, and 0% of patients had grades 0, 1, and 2 to 5, respectively. (HealthDay News) — For patients with haploidentical ...

The Phase II ELM-2 study implemented a step-up dosing strategy to mitigate cytokine release syndrome (CRS), followed by maintenance dosing every two weeks or every four weeks for patients who achieved ...